APRE - Aprea Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APRE is currently covered by 2 analysts with an average price target of $4.1. This is a potential upside of $10.41 (454.05%) from yesterday's end of day stock price of $0.74.

Aprea Therapeutics's activity chart (see below) currently has 10 price targets and 22 ratings on display. The stock rating distribution of APRE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 20.57 days.

Highest price target for APRE is $7, Lowest price target is $1.2, average price target is $4.1.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 31-Mar-2026. First documented stock forecast 28-Oct-2019.

Currently out of the existing stock ratings of APRE, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Mar-2023

$1.2

$0.2 (20.00%)

5 months 22 days ago
(31-Mar-2026)

0/8 (0%)

$0.44 (57.89%)

Buy Since 27-Mar-2024

$7

$6 (600.00%)

5 months 22 days ago
(31-Mar-2026)

0/3 (0%)

$6.24 (821.05%)

Hold

$80

$78.75 (6300.00%)

4 years 6 months 5 days ago
(16-Mar-2022)

1/4 (25%)

$40.2 (101.01%)

44

Hold

$40

$38.75 (3100.00%)

$80

4 years 6 months 5 days ago
(16-Mar-2022)

3/4 (75%)

$0.2 (0.50%)

21

Hold

$500

5 years 1 months 1 days ago
(20-Aug-2021)

2/2 (100%)

$47.6 (10.52%)

16

Show more analysts

Please expand the browser size to see the chart

What is APRE (Aprea Therapeutics) average time for price targets to be met?

On average it took 21 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on APRE (Aprea Therapeutics)?

Joseph Pantginis

Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?

Joseph Pantginis has 71 price targets and 51 ratings on APRE

Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?

Madhu Kumar with the highest potential upside of $98.75

Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?

Jessica Fye with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?